Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 4.485
-0.020 (-0.44%)
At close: Mar 27, 2026
Garofalo Health Care Revenue
In the year 2025, Garofalo Health Care had annual revenue of 487.08M EUR with 4.13% growth. Garofalo Health Care had revenue of 123.91M in the quarter ending December 31, 2025, with 2.88% growth.
Revenue
487.08M
Revenue Growth
+4.13%
P/S Ratio
0.81
Revenue / Employee
192.83K
Employees
2,865
Market Cap
396.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487.08M | 19.31M | 4.13% |
| Dec 31, 2024 | 467.77M | 101.63M | 27.76% |
| Dec 31, 2023 | 366.14M | 46.10M | 14.40% |
| Dec 31, 2022 | 320.04M | 37.12M | 13.12% |
| Dec 31, 2021 | 282.93M | 74.59M | 35.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Pharmanutra | 133.97M |